Two patients with low lactate dehydrogenase (LD) activity were discovered during healthcare examinations and were found to be homozygous for LD-H (heart) subunit deficiency by electrophoretic isoenzyme analysis of serum and erythrocyte hemolysate. The molecular nature of the genetic mutations was characterized by amplification by the polymerase chain reaction and DNA sequencing. In one case, a single-base substitution (T-*G transversion) at codon 147 of the LD-H(B) gene resulted in a nonsense mutation; in the other case, a deletion of 2 base pairs had occurred at codon 139, resulting in a frameshift translation and premature termination. In humans, enzyme deficiencies and variant subunits of either LD-M or LD-H have been reported (4-B). The frequencies of either LD-M or LD-H subunit deficiency were estimated by screening the Japanese population in the Shi.zuoka Prefecture (5) and in the Fukuoka Prefecture (9); the incidence of individuals heterozygous for LD-H deficiency was 0.159% and 0.104%, respectively.
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In mammals, the five tetrameric 
LD-M(A) and LD-H(B)
genes has shown that the protein-coding sequences of these LD genes are interrupted by six introns at homologous positions (2, 3) .
In humans, enzyme deficiencies and variant subunits of either LD-M or LD-H have been reported (4-B) . The frequencies of either LD-M or LD-H subunit deficiency were estimated by screening the Japanese population in the Shi.zuoka Prefecture (5) and in the Fukuoka Prefecture (9); the incidence of individuals heterozygous for LD-H deficiency was 0.159% and 0.104%, respectively. We have investigated the molecular nature of the gonetic mutations in LD-M(A) or LD-H(B) mutant genes (10) (11) (12) (13) (14) .
Here we report our findings of genetic mutations in two patients with complete LD-H deficiency. The deficiency was due to either a nonsense mutation (case 1) or a 2-bp deletion mutation (case 2), resulting in premature termination. (Table 1) was mixed with 2.5 U of Taq polymerase and 1 L of (50-100 ng) DNA extracted from whole blood and subjected to 30 cycles each at 94#{176}C (1 mm), 60#{176}C (2 mm), and 72#{176}C (3 mm).
Primers for polymerase chain reaction (PCR) and sequencing were synthesized on a DNA synthesizer (Applied Biosystems, Foster City, CA) and purified by HPLC. The procedure for silver staining was essentially the same as that described in the Phast System manual (Pharmacia).
Exons displaying conformation polymorphisms were sequenced directly with one of the PCR primers. For preparing single-strand DNA (ssDNA) templates, we used asymmetric PCR (17). After removing excess primer and dNTPs, saDNAs were sequenced by the dideoxy method with Sequenase (United States Biochemical Co., Cleveland, OH).
Restriction enzyme digestion with BstEII (Toyobo, Osaka, Japan) was performed for amplified exon 4. Briefly, 10 L of a reaction mixture containing 10 mmol/L MgC12, 100 mmol/L NaC1, 1 mmol/L clithiothreitol, 50 mmol/L Tris-HC1 (pH 7.5), and 16 U of BstEII and 8 pL of amplified DNA were digested for 2 h at 60#{176}C.
Results
The PCR-DCP analysis indicated abnormal mobilities of the amplified products from both patients (Fig. 1) . Single-stranded DNA for exon 4 of the LD-H(B) gene from patient 1 migrated slightly faster than that from normal individuals. Double-stranded DNA for exon 3 from patient 2 moved slightly more slowly than that from normal individuals.
A mixture of the amplified DNA from patient 2 and a normal individual displayed method to analyze mutations from patient 1 and his brother, both were found to be homozygous for the nonsense mutation (Fig. 3) 6, 18) . We report here two more cases of LD-H(B) subunit deficiency with low LD activity in serum and only a single isoenzyme, LD-5, not only in serum but also in erythrocytes.
In routine analyses of serum LD activity, the diagnostic value of the results is mainly related to increases in activity. However, decreases in serum LD activity can also reflect abnormal states, e.g., LD subunit deficiency or the presence of U) inhibitors. As we reported previously (19), in one case of very low serum U) activity in which only one isoenzyme band migrated near LD-4 (M3H1) upon electrophoresis, the deficiency was caused by inhibition. Thus, low LD activity in serum is potentially subject to misinterpretation in laboratory medicine.
We previously characterized the genetic mutations in two individuals with unstable variants of LD-H (6, 18) and found two homozygous missense mutations in the LD-H(B) gene, Ser to Arg at codon 131 and Arg to His at codon 173 (10, 12) ( Table 2) . We also detected two missense mutations, two duplications, and a deletion of the LD-H(B) gene among individuals heterozygous for LD-H-deficient phenotypes (9, 13) ( Table 2) . We detected nine kinds of mutations in 13 cases of LD-H subunit deficiency (low LD activity and abnormal erythrocyte U) isoenzyme pattern). The genetic mutations in the LD-H(B) gene differed from each other except for a missense mutation (F172V) in exon 4 seen in three individuals in three independent families (13). Two of the five single-base substitutions (B-35, B-173) occurred at a CpG dinucleotide, the mutational "hot spot." There were no differences in LD activity in serum or erythrocytes between the missense and the termination mutations. 
